Sales growth was driven by higher sales of specialty wheat proteins, including textured proteins, and biofuel and other byproducts, partially offset by lower specialty wheat starch sales volumes primarily due to longer-than-expected downtime following a scheduled plant shutdown.
Wilmar attributed the weaker results mainly to higher feedstock costs in its food products business and lower soybean crushing margins in its feed and industrial products segment.
The program started with 5,000 acres and 12 producers growing soft red winter wheat using regenerative practices.
This milestone underscores Kerry’s growing role as a key innovator in the global enzyme market, combining deep biotechnology capabilities with integrated application expertise to solve pressing customer challenges across the food and beverage, biopharma and biotech sectors.
The investments are being implemented in two phases through 2027.